{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT03408730",
      "orgStudyIdInfo": {
        "id": "VBI-2601-201",
        "type": null,
        "link": null
      },
      "secondaryIdInfos": [
        {
          "id": "2017-001820-22",
          "type": "EUDRACT_NUMBER",
          "domain": "EU Clinical Trials Register",
          "link": null
        }
      ],
      "organization": {
        "fullName": "VBI Vaccines Inc",
        "class": "INDUSTRY"
      },
      "briefTitle": "Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine",
      "officialTitle": "Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial",
      "acronym": "CONSTANT"
    },
    "descriptionModule": null,
    "conditionsModule": null,
    "designModule": null,
    "armsInterventionsModule": null,
    "outcomesModule": null,
    "eligibilityModule": null
  }
}